1363OEfficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC
Faivre-Finn, C, Spigel, D R, Senan, S, Langer, C J, Raben, D, Perez, B, Özgüroğlu, M, Daniel, D, Villegas, A, Vicente, D, Hui, R, Murakami, S, Paz-Ares, L, Poole, L, Wadsworth, C, Dennis, P A, AntoniaVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy291
Date:
October, 2018
File:
PDF, 94 KB
english, 2018